Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Emily Leproust, CEO of Twist Bioscience, sold 14,334 shares of common stock on November 6, 2024, to cover tax obligations related to vesting performance stock units.

Summary

  • On November 6, 2024, Emily M. Leproust, CEO of Twist Bioscience, sold 14,334 shares of Twist Bioscience Corp (TWST) common stock.
  • The sale was executed at a price of $44.605 per share.
  • The transaction was to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (PSUs).
  • Following the transaction, Leproust directly owns 589,552 shares of Twist Bioscience common stock.
  • Leproust also holds various employee stock options with different exercise prices and expiration dates.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) by the CEO. It doesn't inherently indicate positive or negative sentiment regarding the company's performance or future prospects.

Industry Context

Executive stock sales are a common occurrence, often related to tax obligations or portfolio diversification. The market typically assesses these sales based on their size relative to the executive's holdings and the overall trading volume of the stock.

Stakeholder Impact

  • The sale could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small size of the transaction.

Key Dates

DateDescription
09/01/201625% of shares subject to one employee stock option vested.
09/28/201710% of shares subject to one employee stock option vested.
09/28/201815% of shares subject to one employee stock option vested.
10/31/201920% of shares subject to one employee stock option vested.
09/01/2020Performance stock options granted to the reporting person.
10/24/202025% of shares subject to one employee stock option vested.
12/19/2022Performance stock options vested and became exercisable.
11/06/2024Emily Leproust sold 14,334 shares of TWST common stock.
11/08/2024Date of signature for the Form 4 filing.
09/28/2025Expiration date for one employee stock option.
09/28/2027Expiration date for one employee stock option.
11/18/2028Expiration date for one employee stock option.
10/23/2029Expiration date for one employee stock option.
08/31/2030Expiration date for one employee stock option.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.